Peter Bains

Chief Business Officer

Peter was appointed Chief Business Officer in 2020 after serving several years as a Non Executive Director. Peter brings three decades of experience in the global pharmaceutical space. Peter has held multiple leadership roles in biopharmaceuticals, most recently as Chief Executive Officer of Sosei Heptares (TSE:4565) and Syngene International (N...

Roles at MiNA Therapeutics

  • Chief Business Officer

    Current role

My work style

How I prefer to work

Qualities I value in my colleagues

Sign up to see more about the team at MiNA Therapeutics

My pet peeves

My communication style

Org chart

Direct reports

No reports


No teams

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.